MSARD

Android App Analysis and Review: MSARD, Developed by Elsevier Inc. Listed in Medical Category. Current Version Is 7.6.0, Updated On 18/01/2020 . According to users reviews on Google Play: MSARD. Achieved Over 2 thousand Installs. MSARD Currently Has 8 Reviews, Average Rating 3.9 Stars

Multiple Sclerosis and Related Disorders (MSARD)

It just got a whole lot easier to keep up with the latest clinical research on MS and associated diseases of the central nervous system. The MSARD app brings you the convenience of reading your favorite journal from anywhere in the world with just a tap. Now available for android smartphones and tablets!
• Stay ahead with alerts when new issues are available and read Articles in Press throughout the month
• Experience innovative digital content with the newly introduced Article enhancements; featuring AudioSlides, Virtual Microscope, 3D Radiological Viewer, 3D Neuroimaging Viewer, and more.
• Get access to the journal content on the app via your institution’s IP
• Enjoy Open Access and Open Archive Content without having to login
• Accessibility support to assist the visually impaired
• Interact with figures, tables, and supplementary content
• Stream multimedia for faster viewing or download for later
• Take notes, highlight articles and share via email and social media
• Personalize your experience with My Reading List and save articles for offline reading
Journal Subscribers: Log in with the same username and password that grants you access to the full journal content on the MSARD website. These credentials will allow full access to all content on the app.

About Multiple Sclerosis and Related Disorders (MSARD)

Multiple Sclerosis is an area of ever expanding research and escalating publications. Multiple Sclerosis and Related Disorders is a wide ranging international journal supported by key researchers from all neuroscience domains that focus on MS and associated diseases of the central nervous system. The primary aim of this journal is the rapid publication of high-quality original research in the field. Important secondary aims are timely updates and editorials on important scientific and clinical care advances, controversies in the field, and invited opinion articles from current thought leaders on topical issues. Another journal focus is teaching ― to enhance the practice of community and academic neurologists involved in the care of MS patients. In addition, summaries of key articles written for a lay audience are provided as an online resource.

Our privacy policy is here: http://www.elsevier.com/EULA_non-Apple_apps

Read more